SEC 13F Intelligence

Knott David M / REGN

Knott David M’s Regeneron Pharmaceuticals Position

Does Knott David M own Regeneron Pharmaceuticals (REGN)? Yes6.0K shares worth $4M (+1.32% of its 13F portfolio) as of Q3 2021.

Position Value
$4M
Q3 2021
Shares
6.0K
% of Portfolio
+1.32%
Quarters Held
2
currently held

Position History REGN

Reported value by quarter
Q2 ’21: $3MQ2 ’21Q3 ’21: $4MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20216.0K$4M+1.32%
Q2 20216.0K$3M+1.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Knott David M’s full portfolio or all institutional holders of REGN.